Ivermectin Nematocides (Ivomec)

Ivermectin, widely known under the brand name Ivomec, is a broad-spectrum macrocyclic lactone antiparasitic medication that has revolutionized the treatment of parasitic infections in veterinary medicine, including avian practice. Derived from avermectins produced by the soil bacterium Streptomyces avermitilis, ivermectin has become one of the most versatile and effective antiparasitic agents available for treating both internal and external parasites in birds. This medication's unique ability to address multiple parasite types simultaneously makes it an invaluable tool in avian medicine, particularly for birds suffering from mixed infestations involving both nematodes and ectoparasites such as mites.

Ivermectin exerts its antiparasitic effects by targeting the nervous system of invertebrate parasites. The drug binds to glutamate-gated chloride channels, which are specific to invertebrate nerve and muscle cells. This binding causes an influx of chloride ions into the cells, resulting in hyperpolarization of nerve and muscle membranes. The consequence is paralysis and eventual death of the parasites. Importantly, these glutamate-gated chloride channels are not present in vertebrate animals, which explains ivermectin's selectivity and safety in host species when used at appropriate doses. The medication is effective against adult parasites and some larval stages, though it does not kill parasite eggs.

Ivermectin is available in multiple formulations suitable for various administration routes in birds. Injectable solutions are commonly used in avian practice, administered either subcutaneously or intramuscularly depending on the bird species and clinical situation. Oral formulations can be given directly into the mouth or, in some cases, added to drinking water for flock treatment. Topical spot-on preparations are particularly convenient for treating external parasites in small pet birds, applied to the skin typically at the back of the neck. The variety of available formulations allows avian veterinarians to select the most appropriate route based on the specific parasites being treated, the bird species, and practical considerations for administration.

While ivermectin is generally safe for most bird species when properly dosed, it requires careful veterinary supervision due to its potency and the critical importance of accurate dosing in small avian patients. The difference between a therapeutic dose and a potentially toxic dose can be small, particularly in tiny birds weighing only a few grams. Certain bird species, notably budgerigars and some finch species, may be more sensitive to ivermectin's effects and require modified dosing protocols. Bird owners should never attempt to treat their birds with ivermectin without professional veterinary guidance, as over-the-counter livestock formulations require precise dilution and calculation for safe use in small companion birds.

Ivermectin is primarily indicated for the treatment of nematode (roundworm) infections in birds, offering effective control of several important gastrointestinal parasites. Ascarid infections, caused by roundworms such as Ascaridia species, are among the most common parasitic conditions treated with ivermectin in avian patients. These large intestinal worms can cause significant morbidity in infected birds, leading to weight loss, poor feather condition, digestive disturbances, and potentially fatal intestinal obstruction in heavy infections. Ivermectin effectively eliminates adult roundworms and many larval stages, making it a reliable choice for treating established ascarid infections and controlling parasite burdens in individual birds and aviary populations.

Beyond its nematocidal activity, ivermectin is extensively used for treating external parasites in birds, which distinguishes it from many other anthelmintic medications. Knemidocoptic mange, commonly known as scaly face or scaly leg mite infestation, is a prevalent condition in budgerigars and other small parrots caused by Knemidocoptes pilae mites. Ivermectin is considered the treatment of choice for this condition, effectively killing the burrowing mites and allowing affected tissues to heal. Similarly, feather mites, red mites, and other ectoparasites that plague pet and aviary birds respond well to ivermectin treatment, making it a versatile option when multiple parasite types are present.

Air sac mites (Sternostoma tracheacolum) represent another important indication for ivermectin use in avian medicine. These respiratory parasites primarily affect finches, particularly Gouldian finches, canaries, and other passerine species, causing respiratory distress, characteristic clicking breathing sounds, and potentially fatal respiratory compromise. Ivermectin's ability to reach therapeutic levels in respiratory tissues makes it effective against these parasites, and treatment often produces dramatic improvement in affected birds. The medication may be administered orally or topically, with repeated treatments typically necessary to eliminate all life stages of the mites.

Ivermectin finds application in various other parasitic conditions depending on the specific pathogens involved and clinical circumstances. Capillaria (hairworm) infections may be treated with ivermectin, although benzimidazole anthelmintics are sometimes preferred for these tissue-dwelling parasites. The medication can be incorporated into comprehensive deworming protocols for quarantine birds or newly acquired aviary additions, addressing multiple potential parasites simultaneously. In poultry medicine, ivermectin serves important roles in controlling roundworm infections and external parasites, though withdrawal periods before egg or meat consumption must be observed.

The selection of ivermectin over alternative antiparasitic medications depends on several factors including the specific parasites identified, the bird species being treated, and practical considerations for administration. Ivermectin's broad spectrum of activity against both internal and external parasites makes it particularly advantageous when mixed infestations are present or suspected. For birds with concurrent roundworm and mite infections, ivermectin can address both problems with a single medication, simplifying treatment protocols. The availability of multiple formulations allows flexibility in administration method, which can be important for birds that are difficult to medicate orally or those too small for injection. Avian veterinarians weigh these advantages against species-specific safety considerations when selecting the most appropriate antiparasitic medication for each patient.

Ivermectin dosing in avian patients demands exceptional precision and should only be determined by a qualified avian veterinarian. The potency of ivermectin means that even small errors in dose calculation can have serious consequences, particularly in small birds where therapeutic margins are narrow. Veterinarians calculate doses based on accurate body weight, the specific parasites being targeted, the formulation being used, and species-specific factors that may influence drug metabolism and sensitivity. Bird owners should never attempt to calculate or administer ivermectin doses independently, as the concentrated livestock formulations commonly available require significant dilution and precise measurement for safe use in companion birds.

Typical ivermectin dosing for birds generally falls within the range of 0.2 to 0.4 milligrams per kilogram of body weight, though this varies based on the target parasite and route of administration. For internal parasites such as roundworms, standard dosing protocols usually involve a single treatment followed by a repeat dose in 10 to 14 days to address parasites that were in egg or early larval stages during initial treatment. External parasite treatments may require different dosing schedules, with some protocols calling for treatment every 7 to 14 days for several doses depending on the parasite life cycle. Topical spot-on applications typically use weight-based dosing with drops applied to bare skin, usually at the back of the neck where the bird cannot preen the medication.

Treatment duration and frequency depend on the specific parasitic infection being addressed and the bird's response to initial therapy. Simple roundworm infections may be effectively controlled with two treatments spaced two weeks apart, while severe mite infestations like knemidocoptic mange often require treatment every 10 to 14 days for four to six treatments until clinical resolution is achieved. Air sac mite infections in finches typically need multiple treatments to eliminate all parasite life stages and may require ongoing monitoring for recurrence. Your avian veterinarian will establish an appropriate treatment schedule based on diagnostic findings and will adjust the protocol based on your bird's response to therapy and follow-up examinations.

Administration of ivermectin to birds varies depending on the formulation prescribed and the specific clinical situation. Injectable ivermectin is typically given subcutaneously, with the injection placed under the skin of the breast or over the back between the wings. This route provides reliable drug absorption and is often preferred for larger birds or when precise dosing is critical. Oral administration involves delivering a measured dose directly into the bird's mouth using a small syringe, ensuring the bird swallows the medication. Topical application of spot-on formulations is commonly used for small pet birds, particularly for external parasite treatment, with drops placed on bare skin at the nape of the neck. Each administration method has specific advantages, and the veterinarian will select the most appropriate route based on the bird's size, the parasites being treated, and practical considerations.

Management of missed doses requires veterinary guidance due to ivermectin's specific pharmacokinetics and the treatment protocols designed around its action. If a scheduled dose is missed, contact your avian veterinarian for specific instructions rather than attempting to adjust the schedule independently. Generally, if a dose is missed by a day or two, it may be given as soon as remembered, with subsequent doses adjusted accordingly. However, doubling doses to compensate for missed treatments is never appropriate and could result in toxicity. Maintaining consistent treatment intervals is important for optimal parasite control, particularly when treating external parasites where interrupting the treatment cycle may allow surviving mites to reproduce.

Completing the entire prescribed treatment protocol is essential for successful parasite elimination with ivermectin. Because ivermectin does not kill parasite eggs, treatment protocols are specifically designed to eliminate parasites as they hatch and develop, requiring multiple treatments at intervals that match parasite life cycles. Stopping treatment prematurely, even if the bird appears improved, can allow surviving parasites to repopulate and may contribute to development of treatment resistance. Follow-up examinations and diagnostic testing help confirm successful parasite elimination and guide decisions about when treatment can be safely discontinued. Bird owners should communicate any concerns about continuing treatment with their avian veterinarian rather than stopping medications independently.

Ivermectin is generally well tolerated by most bird species when administered at appropriate therapeutic doses under veterinary supervision. The medication's selectivity for invertebrate nervous system targets contributes to its favorable safety profile in vertebrate hosts. However, as with any potent medication, adverse effects can occur, and bird owners should be informed about potential reactions to facilitate early recognition and appropriate response. Monitoring birds closely during and after ivermectin treatment allows for prompt identification of any problems that may develop.

Common mild side effects associated with ivermectin treatment in birds are typically transient and self-limiting. Some birds may experience temporary lethargy or decreased activity in the hours following treatment, particularly after injectable administration. Mild gastrointestinal effects including temporary appetite reduction or soft droppings may occur as the medication takes effect and parasites begin to die. Regurgitation shortly after oral administration can occur if the bird becomes stressed during the medication process. At the site of subcutaneous injection, minor local reactions including temporary swelling or discomfort may develop but typically resolve within a few days without intervention.

Moderate side effects warrant closer observation and may require veterinary consultation depending on their severity and duration. Prolonged lethargy extending beyond 24 to 48 hours after treatment, significant appetite suppression lasting more than a day, or notable behavioral changes should prompt contact with the prescribing veterinarian. Neurological symptoms including mild incoordination, head tilting, or balance disturbances may indicate the dose was higher than optimal for that individual bird or species. Some birds may develop temporary vision changes manifested as difficulty judging distances or reluctance to fly. These moderate effects, while usually reversible, indicate the need for veterinary evaluation and potential adjustment of future treatment protocols.

Serious adverse reactions to ivermectin are relatively uncommon but require immediate veterinary attention when they occur. Signs of significant toxicity include severe neurological symptoms such as pronounced ataxia, paralysis, tremors, seizures, or coma. Profound weakness, inability to perch or stand, severe respiratory distress, or complete refusal of food and water all constitute emergency situations. Certain bird species, particularly budgerigars and some finch species, may be more susceptible to ivermectin toxicity at standard doses, and severe reactions in these species should be anticipated as possibilities. Very young birds and those with compromised liver function may also show increased sensitivity to ivermectin's effects.

Rare idiosyncratic reactions and species-specific sensitivities represent additional concerns with ivermectin use in birds. Individual birds may occasionally experience unexpected adverse reactions even at standard doses, possibly due to genetic variations in drug metabolism or underlying health conditions. The die-off of large numbers of parasites following treatment can occasionally trigger inflammatory responses that cause temporary worsening of clinical signs before improvement occurs, a phenomenon sometimes termed the Jarisch-Herxheimer-like reaction. Long-term effects from repeated ivermectin treatments are not well documented in birds, but prudent practice suggests using the medication only when parasites are confirmed present rather than as routine prophylaxis. Any concerning symptoms during or after ivermectin treatment should prompt immediate veterinary consultation to ensure appropriate management and prevent progression of adverse effects.

Ivermectin should not be administered to birds with known hypersensitivity to macrocyclic lactone medications. Birds that have previously experienced adverse reactions to ivermectin, moxidectin, selamectin, or related compounds should be treated with alternative antiparasitic agents from different drug classes. Although true allergic reactions to ivermectin are uncommon in birds, previous adverse events with this medication class warrant selection of alternative treatments. Complete disclosure of any prior medication reactions to your avian veterinarian enables informed prescribing decisions that prioritize your bird's safety.

Severe debilitation, significant organ dysfunction, and compromised health status may preclude or modify ivermectin use in avian patients. Birds with serious liver disease may have impaired ability to metabolize ivermectin safely, potentially leading to drug accumulation and toxicity. Severely ill, dehydrated, or malnourished birds may be at increased risk for adverse effects and typically benefit from stabilization before antiparasitic treatment is initiated. The stress of the dying parasite burden combined with medication effects could potentially overwhelm an already compromised bird. Avian veterinarians assess overall patient health before prescribing ivermectin and may recommend supportive care before or alongside antiparasitic treatment for debilitated patients.

Life stage considerations affect ivermectin prescribing decisions in breeding and developing birds. While ivermectin is not absolutely contraindicated in breeding birds, the potential effects on reproduction and developing embryos warrant careful consideration. Some avian veterinarians prefer to defer elective antiparasitic treatment until breeding activities have concluded. Very young birds, particularly those still being fed by parents or recently weaned, may have different pharmacokinetic profiles than adults and may require modified dosing. Geriatric birds with age-related declines in organ function may similarly need adjusted approaches to ivermectin treatment to account for altered drug metabolism and clearance.

Species-specific contraindications and precautions are particularly important for ivermectin due to documented variations in sensitivity among bird species. Budgerigars have shown increased sensitivity to ivermectin in some reports, and while the medication can be used in this species, careful attention to dosing and monitoring is essential. Certain finch species may also exhibit heightened sensitivity to macrocyclic lactone medications. Conversely, some bird species appear to tolerate ivermectin well even at the upper range of dosing. Chelonians (turtles and tortoises) kept in the same household as birds should never be treated with ivermectin due to extreme toxicity in these animals. Bird owners must provide complete information about their bird's species, age, health status, and any previous medication experiences to allow appropriate assessment of ivermectin suitability.

Complete disclosure of all medications, supplements, and other products your bird receives is essential before ivermectin treatment begins. Drug interactions can affect ivermectin's safety and efficacy in ways that may not be immediately apparent, making comprehensive medication history vital for informed prescribing. Even seemingly innocuous supplements or over-the-counter products could potentially interact with ivermectin metabolism or effects. Your avian veterinarian needs this information to evaluate potential interaction risks and adjust treatment plans accordingly to ensure your bird's safety.

Interactions between ivermectin and other antiparasitic medications require consideration when treating complex parasitic infections. Concurrent use of ivermectin with other macrocyclic lactone drugs such as moxidectin or selamectin should be avoided due to the potential for additive or synergistic effects on the nervous system. When combination antiparasitic therapy is needed, such as combining ivermectin for nematodes with praziquantel for tapeworms, treatments may be staggered rather than administered simultaneously. Benzimidazole anthelmintics like fenbendazole work through entirely different mechanisms and are generally considered safe to use in sequence with ivermectin, though concurrent administration is typically unnecessary and should follow veterinary guidance.

Medications affecting liver enzyme function can potentially alter ivermectin metabolism and blood levels. Drugs that inhibit hepatic enzymes may slow ivermectin metabolism, leading to higher and more prolonged drug exposure that could increase toxicity risk. Conversely, enzyme-inducing medications might accelerate ivermectin clearance, potentially reducing efficacy. Certain antifungal medications, particularly azole antifungals like ketoconazole and itraconazole that are sometimes used in avian medicine, are known to affect hepatic enzyme activity and could theoretically interact with ivermectin. When birds require both antiparasitic and antifungal treatment, veterinary guidance on timing and dosing adjustments helps manage potential interaction risks.

Dietary factors and supplements may influence ivermectin absorption and distribution in ways that affect treatment outcomes. High-fat meals can increase ivermectin absorption from the gastrointestinal tract, potentially affecting drug levels achieved in the body. Vitamin and mineral supplements generally do not have significant direct interactions with ivermectin, though maintaining overall nutritional health supports the bird's ability to tolerate treatment and recover from parasitic infection. Probiotic supplements, often recommended to support digestive health, should be administered at different times than oral ivermectin to prevent any potential interference. Activated charcoal, if used for any purpose, could bind ivermectin in the gut and reduce its absorption, so concurrent administration should be avoided.

Monitoring for potential drug interactions during ivermectin treatment involves observing for signs of altered drug effects or unexpected adverse reactions. Birds receiving concurrent medications should be watched closely for enhanced toxicity signs such as excessive sedation, neurological changes, or other symptoms beyond what would be expected from either medication alone. Your avian veterinarian may recommend altered dosing or timing of medications to minimize interaction risks when multiple drugs are necessary. Any unexpected symptoms or changes in your bird's condition during ivermectin treatment should be reported promptly, especially if the bird is receiving other medications. Never add new medications or supplements during ivermectin treatment without veterinary consultation.

Essential precautions for ivermectin use in birds begin with the fundamental requirement for accurate weight measurement and precise dose calculation. Given ivermectin's potency and narrow therapeutic margins in small birds, even minor errors in dosing can have serious consequences. Bird weights should be obtained using a gram-scale appropriate for the bird's size, ideally on the day of treatment. Medication must be measured with precision instruments such as tuberculin syringes capable of measuring small volumes accurately. Stock livestock ivermectin solutions require significant dilution for avian use, and these dilutions must be prepared accurately, typically by veterinary professionals, to ensure safety.

Species-specific sensitivities to ivermectin represent a critical consideration in avian medicine. Budgerigars have documented increased sensitivity to macrocyclic lactone medications in some reports, and while ivermectin can be safely used in this species, conservative dosing and careful monitoring are particularly important. Some finch species may also exhibit heightened sensitivity, requiring adjusted protocols. Conversely, some parrot species and poultry generally tolerate ivermectin well within established dosing ranges. Raptors have been successfully treated with ivermectin, but species-specific guidelines should be followed. Consulting species-specific veterinary references and working with an avian veterinarian experienced with your particular bird species helps ensure safe treatment approaches.

Environmental and handling precautions protect both birds and their caretakers during ivermectin treatment. Ivermectin solutions should be stored securely away from children and other household pets. While ivermectin has relatively low toxicity to mammals, accidental exposure should be avoided, and hands should be washed after handling the medication. The medication is highly toxic to certain aquatic invertebrates, so proper disposal is important to prevent environmental contamination. Birds treated topically with ivermectin should not be handled excessively immediately after application to minimize human exposure. Treated birds should be prevented from bathing for 24 hours or as directed to allow adequate drug absorption.

Monitoring requirements during ivermectin treatment help ensure both safety and efficacy. Birds should be observed closely for several hours after treatment administration, particularly after the first dose, to detect any early signs of adverse reaction. During the treatment period, daily observation for appetite, activity level, droppings character, and overall behavior helps track response and identify any concerning changes. Signs suggesting treatment efficacy include improved energy, normalized appetite, and resolution of clinical signs related to parasitic infection. Signs requiring veterinary attention include prolonged lethargy, neurological symptoms such as ataxia or tremors, persistent appetite loss, or any dramatic change from baseline behavior.

Special populations of birds require additional consideration when ivermectin treatment is planned. Geriatric birds may have reduced hepatic and renal function affecting drug metabolism and clearance, potentially warranting dose adjustment or extended monitoring. Very young birds, particularly those not yet fully weaned, may have immature metabolic systems and should be treated cautiously with appropriate dose modifications. Immunocompromised birds, including those with concurrent illnesses or stress-related immune suppression, may benefit from supportive care alongside antiparasitic treatment. Breeding birds present considerations related to potential reproductive effects, and elective deworming is often deferred until breeding activities conclude. These special populations benefit from individualized treatment planning that accounts for their specific vulnerabilities and needs.

Proper storage of ivermectin maintains medication potency and ensures treatment safety and effectiveness. Most ivermectin formulations should be stored at controlled room temperature, typically between 59 and 86 degrees Fahrenheit (15-30 degrees Celsius), protected from light and temperature extremes. Some formulations may have specific refrigeration requirements, particularly after opening, so label instructions should be followed carefully. The medication should be kept in its original container with the lid tightly secured to prevent degradation from air and light exposure. Storage locations away from direct sunlight, heat sources, and areas of high humidity help maintain medication stability throughout its shelf life.

Different ivermectin formulations have specific handling requirements that should be observed carefully. Injectable solutions should remain clear and free of particulate matter; any cloudiness, discoloration, or visible particles indicates potential degradation and the product should not be used. Oral formulations should be measured carefully with appropriate syringes or droppers capable of precise small-volume measurement. Topical spot-on preparations should be applied carefully to bare skin where the bird cannot preen or ingest the medication. When diluted ivermectin solutions are prepared from concentrated livestock formulations, these diluted preparations may have limited stability and should be used within the timeframe specified by the preparing veterinarian or pharmacist. Always check expiration dates before use.

Safe handling and disposal of ivermectin protects household members, other animals, and the environment. Store ivermectin products securely away from children and household pets, particularly cats which may be sensitive to macrocyclic lactone medications if exposed. Never administer livestock ivermectin products directly to birds without veterinary guidance and proper dilution, as these concentrated formulations can easily cause fatal overdose in small birds. Disposal of unused or expired ivermectin should follow local regulations for medication disposal. Ivermectin is highly toxic to aquatic organisms, so disposal into waterways or septic systems should be avoided. Many communities offer pharmaceutical take-back programs that provide appropriate disposal options. Compounded ivermectin preparations may have different stability characteristics than commercial products, so specific storage and handling instructions from the compounding pharmacy should be followed carefully.

Ivermectin's effects can vary substantially among different bird species, making species-specific knowledge essential for safe and effective treatment. These variations arise from differences in drug metabolism, body composition, typical parasite burdens, and inherent species sensitivities to macrocyclic lactone medications. Avian veterinarians draw upon published research, clinical experience, and pharmacological principles to develop appropriate treatment protocols for each species. Working with a veterinarian experienced in treating your particular bird species provides the best assurance of safe and effective ivermectin therapy.

Psittacine birds encompass a diverse group with varying responses to ivermectin treatment. Most parrot species, including macaws, cockatoos, Amazon parrots, and African grey parrots, generally tolerate ivermectin well at appropriate doses, though individual monitoring remains important. Budgerigars represent a significant exception, with documented reports suggesting increased sensitivity to macrocyclic lactone medications in at least some individuals of this species. While ivermectin can be used successfully in budgerigars, conservative dosing and careful observation are essential. Cockatiels typically tolerate ivermectin appropriately, and the medication is commonly used to treat scaly face mites in these birds. Smaller psittacines such as parrotlets and lovebirds require very precise dosing due to their small body size, making accurate weight measurement and proper dilution of medication critical for safety.

Passerine birds, including finches and canaries, commonly require ivermectin treatment for air sac mites, a condition particularly prevalent in Gouldian finches. While these birds generally respond well to treatment, their tiny body size presents challenges for accurate dosing. Some finch species may exhibit sensitivity to ivermectin similar to that seen in budgerigars, warranting careful attention to dosing protocols. Topical administration is often preferred for these small birds as it avoids the challenges of oral dosing and provides reliable drug delivery. Canaries typically tolerate ivermectin well and may receive treatment for various internal and external parasites. Other passerines, including softbills and various small songbirds, require species-specific consideration and weight-appropriate dosing.

Larger avian species and specialty birds present their own considerations for ivermectin use. Raptors, including hawks, eagles, falcons, and owls, may receive ivermectin for various parasitic conditions, with dosing based on species-specific guidelines developed for these birds. Poultry including chickens, turkeys, and ducks commonly receive ivermectin for internal and external parasite control, though egg withdrawal periods must be observed in laying birds and meat withdrawal periods in birds intended for consumption. Pigeons and doves generally tolerate ivermectin appropriately. Ratites (ostriches, emus, and rheas) may require specialized dosing protocols appropriate for their unique physiology. Regardless of species, accurate body weight measurement and adherence to established dosing guidelines help ensure safe and effective ivermectin treatment across the diverse range of avian patients.

Several alternative medications within the macrocyclic lactone class may be considered when ivermectin is not ideal or when alternative options are preferred. Moxidectin, another macrocyclic lactone with similar mechanisms but different pharmacokinetic properties, offers an alternative that some avian veterinarians prefer for certain situations or species. Selamectin, available in topical formulations originally developed for dogs and cats, has been used extra-label in birds for both internal and external parasite treatment. These same-class alternatives work through similar mechanisms targeting invertebrate glutamate-gated chloride channels but may have different absorption, distribution, and elimination characteristics that could be advantageous in specific clinical situations. Selection among macrocyclic lactone options depends on the specific parasites being treated, the bird species, and veterinary preference.

Antiparasitic medications from different pharmacological classes provide alternative options when macrocyclic lactones are contraindicated or when different mechanisms of action are desired. Benzimidazole anthelmintics such as fenbendazole work through entirely different mechanisms targeting parasite tubulin and are effective against many of the same nematode parasites as ivermectin. Levamisole provides another alternative mechanism option, causing parasite paralysis through nicotinic receptor stimulation. Pyrantel pamoate may be used for certain roundworm infections as an additional alternative. For birds with concurrent mite infestations who cannot receive ivermectin, alternative ectoparasite treatments may be necessary, though these often have more limited spectra than ivermectin. Praziquantel is the treatment of choice for tapeworm infections, which ivermectin does not effectively address.

Complementary and supportive therapies enhance antiparasitic treatment outcomes and support avian patient recovery. Environmental decontamination is essential alongside ivermectin treatment, particularly for external parasites, to eliminate parasites and eggs in the bird's environment and prevent reinfection. Probiotic supplementation may help restore beneficial gut microbiome populations following antiparasitic treatment. Nutritional support with high-quality diet and appropriate vitamin and mineral supplementation aids recovery from parasitic infection. For air sac mite infections, nebulization therapy may provide adjunctive respiratory support. Any changes to medications or complementary therapies should only be made under avian veterinary direction to ensure compatibility with ongoing treatment and the bird's individual health needs. Never substitute antiparasitic medications or modify treatment protocols without professional veterinary guidance, as improper treatment can result in continued infection, treatment resistance, or harm to your bird.